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Bone morphogenetic protein (BMP) signalling is key to many developmental processes, including early regionalisation of the ectoderm. The neural crest is induced
here by a combination of BMP and Wnt signals from nearby tissues with many secreted factors contributing to its initial specification at the neural plate border.
Gremlin 1 (Grem1) is a secreted BMP antagonist expressed in the neural crest in Xenopus laevis but its function here is unknown. As well as binding BMPs, Grem1 has
been shown to interact with heparan sulfate proteoglycans (HSPGs), a family of cell surface macromolecules that regulate a diverse array of signalling molecules by
affecting their availability and mode of action. This study describes the impact of HSPGs on the function of Grem1 in neural crest induction. It shows for the first time
that Grem1 is required for neural crest development in a two-step process comprising an early HSPG-independent, followed by a late HSPG-dependent phase.1. Introduction
The neural crest is a crucial progenitor cell population arising at the
border of the neural plate during vertebrate embryogenesis. Neural crest
cells migrate throughout the body and differentiate into diverse de-
rivatives, including melanocytes, craniofacial skeleton, and much of the
peripheral nervous system (Simoes-Costa and Bronner, 2015). The neural
crest is specified by a combination of signals including BMPs (Barth et al.,
1999; Marchant et al., 1998; Nguyen et al., 1998; Tribulo et al., 2003),
Wnts (Bang et al., 1999; Chang and Hemmati-Brivanlou, 1998; Garcia--
Castro et al., 2002; LaBonne and Bronner-Fraser, 1998; Saint-Jeannet
et al., 1997), and FGFs (Monsoro-Burq et al., 2003; Nichane et al., 2008)
from the non-neural ectoderm and underlying mesoderm. These signals
are integrated at the neural plate border by a set of key transcription
factors. For instance, Msx1 responds to both active Wnt signalling and
levels of BMP signalling intermediate to those in the neural plate and
non-neural ectoderm to promote Pax3 and Zic1 (Monsoro-Burq et al.,
2005; Tribulo et al., 2003). Pax3 also responds directly to Wnt signalling
(Monsoro-Burq et al., 2005). The combined activity of Pax3 and Zic1
activates specifier genes like foxd3 to initiate neural crest cell migration
and their later differentiation into a wide array of derivatives (de Croze
et al., 2011; Milet et al., 2013; Monsoro-Burq et al., 2005; Sato et al.,
2005).
Grem1 is a member of the Dan family of BMP antagonists, secreted
proteins that directly bind BMPs to obstruct signal transduction (Brazil* Corresponding author.
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expressed in neural crest cells, although its role in their development
remains unknown (Hsu et al., 1998). Like many signalling molecules
(Rider and Mulloy, 2017), Grem1 can also bind to heparan sulfate pro-
teoglycans (HSPGs), cell surface macromolecules that may regulate its
distribution and biological activity (Tatsinkam et al., 2015, 2017). HSPGs
have been shown to mediate Grem1 Vegfr2 agonism, independently from
its role in BMP signalling (Chiodelli et al., 2011). The present study de-
tails a novel requirement for Grem1 in neural crest induction in Xenopus
that depends on its ability to bind HSPGs.
2. Materials and methods
2.1. In vitro transcription and morpholino preparation
Plasmids were linearised by restriction digest and RNA for embryo
microinjection transcribed using the mMessage mMachine Kit (Invi-
trogen). Riboprobes for in situ hybridisation were transcribed using the
DIG RNA Labelling Kit (Roche). Morpholinos (Gene Tools) were prepared
by dissolving in autoclaved, double deionised H2O to the required con-
centration for microinjection. Sequence for grem1 translation-blocking
morpholino 1: GCA TAA ACG AGA CAG TTC ATC CTG T. Sequence for
morpholino 2: CTG GCT CAC AGC AGA TCA AGA CTA G..
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Micropipettes were prepared from glass capillary tubes using a Sutter
P-97 needle puller and embryos injected using a Harvard Apparatus PLI-
100 microinjector. Injection volume was calibrated by adjusting pulse
duration and measuring the size of the droplet in mineral oil over a 0.05
mm graticule. Embryos were immersed in a 3.5% w/v solution of Ficoll
(Sigma) in 0.5x Marc’s Modified Ringer’s solution (MMR) for injection to
prevent leakage and remained in this solution for at least 4 hours post-
injection to allow puncture closure before transfer into 0.1x MMR. For
overexpression and knockdown experiments, injection into the animal
pole of one hemisphere at the two-cell stage was used to target the
ectoderm unilaterally, leaving the contralateral side unaffected,
providing an internal control.
2.3. Fixation and screening
Embryos were fixed in MEMFA for 10 minutes then washed into PBS
for screening and, if necessary, X-gal staining. They were then screened
by epifluorescence microscopy. Embryos were selected based on the
presence of fluorescent lineage tracer, indicating successful injection
uptake, then sorted by location of fluorescence on either the right- or left-
hand side, indicating unilateral targeting. Embryos also injected with
lacZ were assessed for the presence of β-galactosidase by incubation at
37C with X-gal solution until suitable staining was observed. All embryos
were fully fixed for a further 50 minutes in MEMFA to total 1-hour overall
fixation. They were then dehydrated by washing twice in methanol and
stored at -20C.
2.4. In situ hybridisation
Embryos were gradually rehydrated by a decreasing methanol series
before bleaching. This was followed by six washes in PBS. Embryos were
equilibrated in hybridisation buffer at 60C for 1 hour then were hybri-
dised overnight with 1 μg/ml riboprobe.
Excess riboprobe was washed out with fresh hybridisation buffer.
Embryos were then washed once in 2x SSC, twice in 0.2x SSC, and once in
maleic acid buffer (MAB), prior to blocking in 2% w/v blocking reagent
(Roche) in MAB for 1 hour. Embryos were then incubated with anti-DIG
antibody conjugated to alkaline phosphatase (Roche) in blocking solu-
tion at 4C overnight.
Excess antibody was removed by a series of five MAB washes of 1
hour at room temperature, followed by an additional overnight wash.
Embryos were equilibrated in NTMT and colour reaction performed in
the dark in NBT/BCIP (Roche) diluted 1:200 in NTMT until suitable
staining was observed.
2.5. Sectioning
Whole-mount stained embryos for sectioning were fixed in 4% w/v
paraformaldehyde at 4C overnight then washed thoroughly in PBS. They
were then equilibrated in molten 20% w/v gelatine at 50C. Embryos
were embedded in gelatine and the blocks trimmed before fixation in 4%
w/v paraformaldehyde for a further 3-5 days then washed in PBS. Blocks
were sectioned on a Leica VT1000 S vibratome to a thickness of 50 μm
and mounted on slides in 90% v/v glycerol under a coverslip.
2.6. qPCR
Total RNA was extracted from whole embryos with 500 μl TRIzol
(Invitrogen) and resuspended in autoclaved, double deionised H2O.
Random hexamer primers were annealed at 65C for 4 minutes then left
on ice before cDNA was reverse transcribed with SuperScript II (Invi-
trogen) at 42C for 30 minutes. qPCR was performed using a SensiMix
SYBR Hi-ROX Kit (Bioline) and the following primers: grem1f TGG GCA
ATG CAA CTC CTT CT, grem1r GTG GGA GGT TGT AGC TCT GG, odc1f TGC109TTT GCT GGT TCT AGT TAC TG, odc1r GTA CCC ATC GAG GCC ACA AA.
Amplification was run on a Lightcycler 480 (Roche) in 96-well plates
with the following parameters: initial denature 10 minutes 95C, 40
amplification cycles, denature 15 seconds 95C, anneal 30 seconds 60C,
elongate 30 seconds 72C, final melt curve to check primer specificity.
Expression of grem1 was normalized to odc1 and given relative to that at
NF stage 36.
3. Results and discussion
3.1. Endogenous Grem1 expression
To determine the function of Grem1 in neural crest development, we
first investigated its endogenous expression. Transcriptomic studies,
including microarray (Yanai et al., 2011) and RNA-Seq (Session et al.,
2016) approaches have detected early grem1 expression in Xenopus
around the time of gastrulation, when neural crest induction occurs. This
was verified here using qPCR, which showed the same profile of early
expression, followed by a slight fall then a gradual rise (Fig. S1).
Later in development tissue-specific expression is detectable by in situ
hybridisation (Hsu et al., 1998). At tailbud stages expression is seen in
the cranial neural crest (Fig. 1A), within the periocular mesenchyme
(Fig. 1B) and dorsal pharyngeal region (Fig. 1C). The function of
neural-crest-derived Grem1 is unclear but in chickens it has been linked
with the maintenance of forebrain development (Creuzet, 2009), and
craniofacial myogenesis (Tzahor et al., 2003). Due to the early onset of
grem1 expression (Session et al., 2016; Yanai et al., 2011), preceding
neural fold stages, and its later expression in migratory neural crest cells,
we investigated its requirement in initial neural crest specification.
3.2. Grem1 is required for neural crest development
To examine the role of Grem1 in neural crest specification we first
analysed the expression of twist1, a cranial neural crest marker (Hopwood
et al., 1989; Fig. 1D). Unilateral overexpression by injection of Xenopus
grem1 RNA caused an expansion in twist1 expression (Fig. 1E), indicating
an increase in neural crest cells. Knockdownwas achieved with the use of
an antisense, translation-blocking morpholino. While injection of a
standard control morpholino had no effect on twist1 (Fig. 1F), injection of
the grem1 morpholino caused a severe reduction (Fig. 1G), indicating
disrupted neural crest formation. This was replicated with a second
morpholino to ensure specificity (n ¼ 23/36; data not shown).
To test the functional conservation of Grem1 with its mammalian
counterpart, the effect of the mouse orthologue was also analysed. In-
jection of murine Grem1 RNA also caused a substantial expansion in
twist1 expression (Fig. 1H), indicating that the proteins are conserved
with respect to neural crest specification. Murine Grem1, which escapes
inactivation by the Xenopus-specific morpholino due to mismatches in the
sequence flanking the start codon, was subsequently used for rescue
experiments. Compared to embryos injected with a control morpholino
(Fig. 1I), bilateral knockdown caused a reduction in neural crest on both
sides (Fig. 1J). Subsequent unilateral supplementation with murine
Grem1 successfully rescued the neural crest on the injected side (Fig. 1K).
Minimal lateral shift suggested that the neural plate was not dramatically
expanded, as might be expected of a generic BMP antagonist, but that
Grem1 specifically affects the neural crest. The ability to rescue the
morphant phenotype also demonstrated specificity of the morpholino,
eliminating the possibility of off-target effects.
To ensure that this was a general effect on the neural crest, several
additional markers were examined. The neural crest specifier sox10 (Aoki
et al., 2003; Fig. 1L) was also reduced after knockdown (Fig. 1M), con-
firming that Grem1 is required, and was correspondingly expanded by
overexpression (Fig. 1N). Another general neural crest marker, foxd3
(Sasai et al., 2001; Fig. 1O), was similarly reduced after knockdown
(Fig. 1P), and was also expanded by overexpression (Fig. 1Q). This
validated the importance of Grem1 for neural crest specification.
Fig. 1. Endogenous grem1 expression pattern,
and effects of knockdown and overexpression on
the neural crest. (A–C) Stage 36 grem1 expression
pattern. (A) Whole-mount stained embryo showing
strong expression in the kidney primordia (k), pos-
terior roofplate (rp) and tailbud (tb), and neural crest
(nc). (B-C) Transverse sections from an embryo like
the one shown, with approximate anteroposterior
locations marked by dashed lines in A. (B) In the
most anterior region, grem1 is expressed in neural
crest cells ventral to the developing eye fields (e). (C)
In the pharyngeal region, expression is seen in neural
crest cells flanking the neural tube (nt) and invading
the tissue around the pharyngeal pouches (pp). (D–E)
Effect of grem1 overexpression on the neural crest.
(D) Cranial neural crest (nc) around stage 18 is
marked by the expression of twist1, flanking the
anterior neural plate. (E) Overexpression by injection
of Xenopus grem1 RNA causes a substantial expansion
(arrowhead) of the neural crest (n ¼ 12/19). (F–G)
Effect of grem1 knockdown. (F) At stage 21 twist1
marks the neural crest as it begins to surround the
eye fields (e) and to migrate in two more posterior
streams. It is unaffected by unilateral injection of a
standard control morpholino (n ¼ 30/30). (G)
Knockdown of grem1 by injection of a translation-
blocking morpholino severely impairs neural crest
formation (asterisk, n ¼ 80/93). (H) Injection of
murine Grem1 RNA is also able to expand the domain
of twist1 expression (arrowhead), indicating func-
tional conservation between the mouse and Xenopus
orthologues (n ¼ 59/74). (I–K) Rescue of neural crest
formation with murine Grem1. (J) Bilateral grem1
knockdown depletes the neural crest from both sides
(asterisks). (K) Unilateral rescue using murine Grem1
RNA, mismatched with the morpholino, which only
targets the Xenopus orthologue, is able to restore
neural crest development (arrowhead, n ¼ 14/20).
(L–Q) Effect of gain and loss of grem1 on other neural
crest markers. (L) Control neural crest expresses
sox10 (n ¼ 25/25). (M) Unilateral grem1 knockdown
abolishes expression on the injected side (asterisk, n
¼ 19/24). (N) Unilateral overexpression expands the
domain of sox10 (arrowhead, n ¼ 21/30). (O) Con-
trol neural crest also expresses foxd3. (P) Knockdown
similarly abolishes expression (asterisk, n ¼ 24/24).
(Q) Likewise, the domain is expanded by over-
expression (arrowhead, n ¼ 12/15). Embryo in A is
shown in side view with anterior towards the left,
sections in B-C are transverse with dorsal towards the
top, and embryos in D-Q are shown in frontal view.
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Neural crest induction is part of the more general process of ectoderm
regionalisation. The effect of Grem1 knockdown and overexpression on
the neural crest prompted an analysis of its effects on other genes
involved in ectoderm patterning. The neural plate expresses sox2 (Miz-
useki et al., 1998; Fig. 2A), and, unlike twist1, sox10, and foxd3, was
maintained after knockdown (Fig. 2B). Although sox2 was expanded by
overexpression (Fig. 2C), the expansion was less pronounced than those
of the neural crest markers. Grem1 is therefore sufficient but not required
for neural induction.110In addition to this general marker, some more specific genes were
examined to assess any changes along the anteroposterior axis. Expres-
sion of otx2 in the forebrain and midbrain (Pannese et al., 1995; Fig. 2D)
was moderately reduced in the most rostral part after Grem1 knockdown
(Fig. 2E), but overexpression had no clear effect (Fig. 2F). Expression of
emx1 in the anterior forebrain (Pannese et al., 1998; Fig. 2G) was lost
after knockdown (Fig. 2H), but also unaffected by overexpression
(Fig. 2I). These results suggested that Grem1 is also required for the
specification of the anterior neural plate. The effect on both the neural
crest at the lateral border and the anterior forebrain at the rostral border
may reflect a general requirement for neural plate border specification.
Fig. 2. Grem1 affects regionalisation of the ecto-
derm and is required for neural plate border
formation. (A, D, G, J, M, P, S) Control embryos, (B,
E, H, K, N, Q, T) unilateral Grem1 knockdown, (C, F,
I, L, O, R, U) unilateral murine Grem1 overexpression.
(A–I) Stage 17 embryos assayed for neural plate
markers, (J–R) stage 14 embryos assayed for neural
plate border markers, and (S–U) stage 11 embryos
assayed for mesoderm markers. (A–C) The neural
plate (np) expresses sox2, which appears to be unaf-
fected by control morpholino (n ¼ 25/25) or loss of
Grem1 (n ¼ 26/26) but is expanded (arrowhead) by
overexpression (n ¼ 20/33). (D–F) Prospective
midbrain and forebrain (fb) regions express otx2,
which is unaffected by control morpholino (n ¼ 24/
24), while the most anterior part is reduced by
knockdown (n ¼ 5/25). It is unaffected by Grem1
overexpression (n ¼ 16/16). (G–I) The future telen-
cephalon (t) expresses emx1, which is unaffected by
control morpholino (n ¼ 17/17), requires Grem1
(asterisk, n ¼ 17/25), but is unaffected by over-
expression (n ¼ 18/18). (J–L) The neural plate
border (npb) is marked by msx1, which is unaffected
by control morpholino (n ¼ 19/19), lost (asterisk)
after Grem1 knockdown (n ¼ 30/45), and expanded
(arrowhead) by overexpression (n ¼ 21/26). (M–O)
It is also marked by pax3, which is unaffected by
control morpholino (n ¼ 19/19), does not require
Grem1 expression (n ¼ 21/23), but can be similarly
expanded (arrowhead) by overexpression (n ¼ 20/
24). (P–R) Likewise, zic1, which is expressed addi-
tionally in the anterior neural fold, is unaffected by
control morpholino (n ¼ 18/18) or knockdown (n ¼
25/25) but expanded (arrowhead) by exogenous
Grem1 (n ¼ 21/23). (S–U) The mesoderm (m) ex-
presses tbxt (S), which is unaffected by either Grem1
knockdown (n ¼ 8/8) or overexpression (n ¼ 8/8).
Embryos in A-R are shown in frontal view with
dorsal-posterior towards the top. Embryos in S–U are
shown in vegetal view.
J. Pegge et al. Developmental Biology 460 (2020) 108–114The ability of exogenous Grem1 to affect sox2 (Fig. 2C) but not otx2
(Fig. 2F) or emx1 (Fig. 2I) indicates that the expanded neural plate pos-
sesses altered positional identity.
To determine the position of Grem1 in the neural crest induction
cascade, several upstream markers of the neural plate border were111examined. Expression of msx1 in the neural plate border (Suzuki et al.,
1997; Fig. 2J) was reduced after knockdown (Fig. 2K) and expanded after
overexpression (Fig. 2L). Expression of pax3 in the anterior neural plate
border (Bang et al., 1997; Fig. 2M) was unaffected by loss of Grem1
(Fig. 2N) but also expanded by overexpression (Fig. 2O). Likewise, zic1,
J. Pegge et al. Developmental Biology 460 (2020) 108–114which is additionally expressed in the anterior neural fold (Mizuseki
et al., 1998; Fig. 2P), was unaffected by knockdown (Fig. 2Q) but
expanded by exogenous Grem1 (Fig. 2R). The expansion of all these
markers after overexpression demonstrates that Grem1 is sufficient to
expand the neural plate border. The effect of knockdown on msx1
(Fig. 2K), foxd3 (Fig. 1P) sox10 (Fig. 1M), and twist1 (Fig. 1G,J), indicates
a fundamental requirement in the neural crest induction programme at
this region.
3.4. Grem1 is not required for mesoderm specification
The mesoderm marker tbxt (also known as brachyury or xbra, Smith
et al., 1991; Fig. 2S) was also examined to determine whether the effect
of Grem1 on the neural crest and neural plate border was due to defects in
mesoderm specification impairing signalling to the ectoderm. No clear
change was seen after either Grem1 knockdown (Fig. 2T) or over-
expression (Fig, 2U). This implies that Grem1 is not required for meso-
derm specification.
3.5. The activity of Grem1 in vivo is dependent on HSPG binding
Grem1, like many secreted signalling proteins, is able to bind cell
surface HSPGs, which can modulate its biological activity (Chiodelli
et al., 2011; Tatsinkam et al., 2015, 2017). Two mutant GREM1 (MGR)
proteins with impaired HS binding have been well-characterised. Their
expression levels in cell culture and their affinity to BMP4 were com-
parable to wild-type GREM1 (Tatsinkam et al., 2015, 2017). These were
used here to investigate the impact of HSPGs on the activity of Grem1 in
vivo. The mutants contain non-conservative substitution mutations in key
arginine and lysine residues, within the mapped clusters that mediate HS
binding (Fig. 3A).
Xenopus laevis has proven to be an invaluable model organism for
linking molecular function to biological relevance. Indeed, Grem1 was
originally identified and defined as a BMP antagonist by an axis induc-
tion screen in Xenopus (Hsu et al., 1998). This approach was used again112here to compare the mutants with the wild-type protein. Embryos were
injected with RNA into a ventral blastomere at the four-cell stage and
assessed at tailbud stages for the presence of a secondary axis. Coinjected
gfp was used as a lineage tracer and alone had no effect (Fig. 3B,B0).
Wild-type GREM1, as expected, was able to induce a secondary axis
(Fig. 3C,C0), a readout for BMP antagonism. However, neither MGR5
(Fig. 3D,D0) norMGR6 (Fig. 3E,E0) could induce a secondary axis at any of
the tested doses (Fig. 3F). Independently from its affinity to BMPs,
therefore, the ability of Grem1 to efficiently inhibit BMP signalling relies
on unimpaired HS binding. HSPGs may facilitate its activity directly at
the cell surface or alter its distribution and availability in the extracel-
lular space. Experiments in cell culture have shown a modest reduction in
BMP inhibition by MGR5 and MGR6 compared with wild-type GREM1,
however they have both conserved their BMP activity and still function as
BMP antagonists (Tatsinkam et al., 2017). The present findings indicate
that HSPGs are essential for the neural crest inducing activity of Grem1 in
vivo.
3.6. HSPG binding is required for neural crest but not neural plate border
specification by Grem1
The requirement for Grem1 to bind HSPGs to induce neural plate
border was also investigated. As in the earlier experiments (Fig. 2J-R),
embryos were analysed at stage 14 formsx1 (Fig. 4A), pax3 (Fig. 4D), and
zic1 (Fig. 4G) expression. Unexpectedly, in contrast to their loss of
function in the axis induction assay (Fig. 3), both constructs retained the
ability to expand the expression ofmsx1 (Fig. 4B-C), pax3 (Fig. 4E-F), and
zic1 (Fig. 4H-I). Effective HSPG binding, therefore, is not required for the
initial inductive capacity of Grem1 at the neural plate border.
The effect of the mutants on the neural crest itself was then tested. As
before (Fig. 1D–K), embryos were analysed at the neurula stage for twist1
expression (Fig. 4J). Again, unilateral Grem1 overexpression caused an
expansion on the injected side (Fig. 4K). However, neither MGR5
(Fig. 4L) nor MGR6 (Fig. 4M) could do the same. Similar results were
found for sox10 (Figs. S2A–C). However, foxd3 was affected by MGR5Fig. 3. The activity of Grem1 in vivo is
dependent on HSPG binding. (A) Sequence
alignment of the cysteine knot domains of
the wild-type mouse protein and two mutant
Grem1 (MGR) constructs with impaired HS
binding. Residues of the characteristic eight-
membered cysteine knot are highlighted in
yellow, with key basic residues mediating HS
affinity in green, and non-conservative sub-
stitutions of these residues in red. (B–F) Axis
induction assay by ventral misexpression of
the indicated genes, traced by coinjected gfp
(B–E), and assessed morphologically (B0-E’)
for formation of a conjoined secondary axis.
(B) Injection of gfp alone has no effect. (C)
150 pg Grem1, as expected, is able to induce
a secondary axis (arrowhead). (D) This abil-
ity is abolished in MGR5. (E) The same goes
for MGR6. (F) Graph summarising results of
axis induction assay across a range of doses:
200 pg gfp (n ¼ 0/92), 50 pg Grem1 (n ¼ 73/
78), 150 pg Grem1 (n ¼ 31/32), 300 pg
Grem1 (n ¼ 7/7), 500 pg grem1 (n ¼ 3/3),
50 pg MGR5 (n ¼ 0 /41), 150 pg MGR5 (n ¼
0/55), 300 pg MGR5 (n ¼ 0/24), 500 pg
MGR5 (n ¼ 0/18), 50 pg MGR6 (n ¼ 0/39),
150 pg MGR6 (n ¼ 2/49), 300 pg MGR6 (n
¼ 0/27), 500 pg MGR6 (n ¼ 0/31). All em-
bryos are oriented with anterior towards the
left.
Fig. 4. HSPG binding is required for neural crest but not neural plate border specification by Grem1. (A–I) Stage 14 embryos assayed for neural plate border
markers. (A, D, G) Control embryos, (B, E, H) unilateral MGR5 expression, (C, F, I) unilateral MGR6 expression. (A–C) msx1 expression at the neural plate border is
unexpectedly expanded and upregulated by bothMGR5 (n ¼ 6/8) andMGR6 (n ¼ 7/9). (D–F) pax3 is similarly affected byMGR5 (n ¼ 7/9) andMGR6 (n ¼ 5/9). (G–I)
The same goes for zic1, with MGR5 (n ¼ 7/7) and MGR6 (n 7/7). (J–R) Stage 18 embryos assayed for twist1 expression. (J) The cranial neural crest (nc) is marked by
twist1. (K) As expected, unilateral overexpression of grem1 RNA, expands the neural crest on the injected side (arrowhead). (L–M) The same dose of MGR5 (L, n ¼ 26/
26) orMGR6 (M, n ¼ 29/29) is unable to elicit an expansion. (N–R) Neural crest induction rescue experiment. (O) Bilateral Grem1 knockdown severely impairs neural
crest formation (asterisks). (P) As before, unilateral supplementation with 100 pg wild-type mouse grem1 restores neural crest development (arrowhead). (Q–R)
Accordingly, the same dose of MGR5 (Q, n ¼ 17/17) or MGR6 (R, n ¼ 15/16) is unable to rescue the neural crest. (S) Schematic summarising a working model for the
function of Grem1 in neural crest induction. (i) BMP (blue) antagonism from the organiser initially induces neural identity in the ectoderm. (ii) Wnt (pink) from the
underlying mesoderm and non-neural ectoderm, and Grem1 (yellow), perhaps also from the underlying mesoderm, signals to the future neural plate border, inde-
pendently of HSPGs. (iii) HSPGs in the neural plate border stabilise and/or modulate the activity of Grem1 protein in this tissue. (iv) This enables the eventual in-
duction of the neural crest. Embryos are shown in frontal view with dorsal-posterior towards the top.
J. Pegge et al. Developmental Biology 460 (2020) 108–114and MGR6 in a minority of cases (Figs. S2D–F). This may represent a
more upstream position in the neural plate border and neural crest in-
duction cascade. These findings were supported by attempts to rescue
neural crest induction (Fig. 4N–R). As in the previous rescue experiment
(Fig. 1I–K), bilateral morpholino knockdown caused a severe reduction
in expression (Fig. 4O), but subsequent unilateral injection of murine
Grem1 was sufficient to restore it again (Fig. 4P). Again, neither MGR5
(Fig. 4Q) nor MGR6 (Fig. 4R) could do the same. This demonstrated that
functional HSPG binding is essential for the capacity of Grem1 to induce
neural crest, for which it is endogenously required.
The effect of the mutants on the neural plate border was confirmed by
a similar rescue experiment (Figs. S2G–K). Bilateral knockdown obliter-
ated msx1 expression (Fig. S2H), which was partially rescued by Grem1,
as expected (Fig. S2I). Interestingly, both MGR5 (Fig. S2J) and MGR6
(Fig. S2K) were also able to rescue msx1. This confirmed that HSPG113binding is not required for the upstream activity of Grem1 at the neural
plate border.
4. Conclusion
The experiments presented in this study demonstrate a novel role for
Grem1 in neural crest induction. Furthermore, they show that this
function is regulated by HSPGs. Grem1 acts independently of HSPGs to
first induce neural plate border genes such as msx1. It then enters a
second, HSPG-dependent phase to allow the expression of neural crest
specifiers (Fig. 4S). The results of this study highlight the importance of
interactions between HSPGs and components of key signalling pathways
during embryonic development.
Whether HSPGs simply stabilise Grem1 protein sufficiently to main-
tain its inductive activity, or whether they also modulate its interactions
J. Pegge et al. Developmental Biology 460 (2020) 108–114with other molecules remains to be seen. For example, HSPGs have been
shown to mediate Vegfr2 agonism by Grem1, indicating that they can
impact its effects on pathways other than BMP signalling (Chiodelli et al.,
2011). Furthermore, VEGF signalling has previously been linked to
neural crest migration so it is reasonable to suggest that HSPG-dependent
VEGF signalling may be involved in other aspects of neural crest devel-
opment, such as induction (McLennan et al., 2015). Our data suggest that
the effect of Grem1 on BMP signalling and potentially VEGF and other
pathways is dependent on the presence and perhaps the composition of
surrounding HSPG molecules. This study represents the first evidence of
a role for Grem1 in neural crest specification and reveals a novel role for
HSPGs during this process.
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